A BMJ analysis warns that the UK-US pharmaceuticals deal could divert up to £45 billion from other NHS services by 2036, with knock-on costs landing squarely on adult social care. For commissioners already stretched thin, the real question is not whether the deal delivers cheaper medicines, but what it quietly takes away.
Continue reading UK-US Trade Deal Could Divert £45 Billion From NHS Care by 2036